Search through
Glucosylceramide (d18:1/22:0) (CAS 2304-81-6) is a vital sphingolipid biomarker and structural component within the US API intermediates market, increasingly utilized by high-growth biotech hubs in Massachusetts and California for the development of lipid-based drug delivery systems where Pharma/API purity 99% is required to meet rigorous American Chemical Society and FDA standards. N-Docosanoyl-beta-D-glucosylsphingosine serves as a specialized high purity fine chemical for North American CDMOs focusing on rare metabolic disease research and lysosomal storage disorder therapeutics, reflecting a strategic shift toward domestic custom synthesis services to ensure supply chain transparency and regulatory compliance. C22 Glucosylceramide is also a fundamental building block for general industry research at a purity of 98%, where its role in cellular signaling and membrane proteomics is essential for academic and commercial laboratory advancements across the United States. We are an established Glucosylceramide (d18:1/22:0) intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Glucosylceramide (d18:1/22:0) COA/TDS/SDS region-specific regulatory support, reliable lead times, worldwide supply chain capabilities
Glucosylceramide (d18:1/22:0) (CAS 2304-81-6) is a vital sphingolipid biomarker and structural component within the US API intermediates market, increasingly utilized by high-growth biotech hubs in Massachusetts and California for the development of lipid-based drug delivery systems where Pharma/API purity 99% is required to meet rigorous American Chemical Society and FDA standards. N-Docosanoyl-beta-D-glucosylsphingosine serves as a specialized high purity fine chemical for North American CDMOs focusing on rare metabolic disease research and lysosomal storage disorder therapeutics, reflecting a strategic shift toward domestic custom synthesis services to ensure supply chain transparency and...
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Intermediates & Precursors
.7767eb0f.png)
Chemical Properties & Specifications
An endogenous glucosylceramide and intracellular metabolite used as a biomarker to study membrane stability, water permeability barriers in the skin, and lipid microdomain behavior
A ubiquitous metabolite that acts as an endogenous Mincle ligand to signal cell damage and trigger inflammatory or acquired immune responses
A high-purity synthetic lipid or isotopically labeled variant used as an internal standard for the absolute quantification of molecular species in LC-MS workflows
A core building block in the sphingolipid pathway used as a starting material for the synthesis of complex glycosphingolipids such as lactosylceramides and gangliosides
A target molecule for investigating metabolic dysregulation in lysosomal storage disorders like Gaucher disease and neurodegenerative conditions including Alzheimer's and Parkinson's.
1/22:0) and what is it used for?: Glucosylceramide (d18:1/22:0), also known as C22 Glucosylceramide, is an endogenous glycosphingolipid consisting of a ceramide backbone linked to a glucose molecule. it is a major constituent of skin lipid membranes, a precursor for complex glycosphingolipids like lactosylceramides and gangliosides, and serves as a biomarker for metabolic and cardiovascular research
1/22:0)?: This compound is primarily used in the pharmaceutical, biotechnology, and diagnostic industries for research into cell signaling, neurodegenerative diseases, immunology, and metabolic disorders
It is compatible with organic solvents like DMSO and methanol and is typically used in lipidomics workflows, LC-MS quantification, and membrane biology research protocols
Standard specifications include high purity (typically ≥97% or ≥98%), structural verification via MS/MS or NMR, and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
1/22:0) export ready and what is the MOQ?: The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Calcium acetate monohydrate (CAS No: 5743-26-0) occupies a critical position in the global specialit...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...
